Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(421/week)
Manufacturing
(319/week)
Technology
(320/week)
Energy
(213/week)
Other Manufacturing
(264/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Monoclonal antibodies
Mar 10, 2018
Praluent® (alirocumab) Injection significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lower death rate
Mar 10, 2018
Sanofi and Regeneron announce plans to make Praluent® more accessible and affordable for patients with the greatest health risk and unmet need
Mar 10, 2018
Regeneron and Sanofi Announce Plans to Make Praluent® (alirocumab) More Accessible and Affordable for Patients with the Greatest Health Risk and Unmet Need
Mar 08, 2018
Global Biosimilar Monoclonal Antibodies Forecast 2018-2028 - Visiongain Report
Mar 08, 2018
Next Generation Biologics, Janssen's Tremfya, Eli Lilly's Taltz, and Novartis' Cosentyx, Raising the Bar in Psoriasis Management
Mar 07, 2018
Aevi Genomic Medicine Expands Collaboration with Kyowa Hakko Kirin
Mar 06, 2018
ProMIS Neurosciences Lead Product Candidate for Alzheimer's Disease Shows Potential for Improved Therapeutic Potency versus Other Amyloid Beta-Directed Antibodies
Mar 06, 2018
Apexigen and the Pediatric Brain Tumor Consortium Announce a Clinical Collaboration to Evaluate APX005M in Children with Brain Tumors
Mar 05, 2018
Global Psoriasis Pipeline Drugs Market 2018-2023: Cimzia (Certolizumab Pegol), Tildrakizumab (MK-3222), Risankizumab (BI 655066), FP187, Skilarence (LAS41008) & Duobrii (IDB 118)
Mar 02, 2018
FDA to Review DUPIXENT® (dupilumab) as Potential Treatment for Moderate-to-Severe Asthma
Feb 27, 2018
Xencor Reports Fourth Quarter and Full Year 2017 Financial Results
Feb 23, 2018
Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditional Marketing Authorisation in Europe for the Treatment of X-Linked Hypophosphatemia in Children
Feb 22, 2018
Xencor Doses First Patient in Phase 1 Study of XmAb®18087 Bispecific Tumor Targeting Antibody for the Treatment of Neuroendocrine Tumors and Gastrointestinal Stromal Tumors
Feb 21, 2018
Global Monoclonal Antibodies Market Hit $100 Billion in 2017: Report
Feb 20, 2018
Xencor to Host Fourth Quarter and Full Year 2017 Financial Results Webcast and Conference Call on February 27, 2018
Feb 17, 2018
AbbVie Presents New Positive Late-Breaking Data from Two Phase 3 Psoriasis Trials of Risankizumab at the 2018 American Academy of Dermatology Annual Meeting
Feb 16, 2018
US FDA APPROVES IMFINZI® (DURVALUMAB) FOR UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER
Feb 16, 2018
FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing
Feb 16, 2018
UCB Advances Psoriasis Pipeline with Positive Data at American Academy of Dermatology Annual Meeting (AAD 2018)
Feb 16, 2018
New TREMFYA® (guselkumab) Data Demonstrates Long-Term Skin Clearance In Patients With Moderate To Severe Plaque Psoriasis
‹‹
Page 36
››
Latest News
Mar 29, 2024
Dawson-Forté Cashmere Shareholders Sell Majority Equity Stake to Tempus Partners
Mar 29, 2024
Terragia Secures $6M to Develop Cost-Competitive, Low-Carbon Biofuel Technology
Mar 29, 2024
Sila Moses Lake Manager Rosendo Alvarado to Speak at Big Bend Community College Building the Future Energy...
Mar 28, 2024
White (Natural) Hydrogen Research Report 2024 Featuring Industry Leaders - Helios, Natural Hydrogen Energy,...
Mar 28, 2024
Asia-Pacific Satellite and Spacecraft Subsystem Industry Research 2023-2033: New Space Business Scenarios, 3D...
Mar 28, 2024
Europe Power Supply Equipment Market for Water Electrolysis Industry Research 2023-2032: Lucrative Demand and...
Mar 28, 2024
NewMarket Corporation Schedules Conference Call and Webcast to Review First Quarter 2024 Financial Results
Mar 28, 2024
Details of “SusHi Tech Tokyo 2024” Showcase Program Announced
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events